Fw: Ref.: (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 122, August 2024

 

Leprosy Mailing List –  August 29,  2024

 

Ref.: (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 122, August 2024

From:  Takahiro Nanri, Tokyo, Japan

---

 

 

Dear Dr. Schreuder and Friends,  

 

 

Warm greetings from Sasakawa Health Foundation/ Sasakawa Leprosy (Hansen's Disease) Initiative in Tokyo.

We have issued WHO Goodwill Ambassador's Leprosy Bulletin NO.122 August 2024 "Driving progress towards zero leprosy in Africa" In this issue, we feature: 

 

MESSAGE FROM THE AMBASSADOR
During the COVID-19 pandemic, when leprosy elimination activities stalled worldwide, the negative effects in Africa were especially severe. In many places on the continent, affected persons cannot receive diagnosis or treatment, and unjust discrimination against persons affected by leprosy and their family members continues. Read More 

 

50th Anniversary of WHO–TNF/SHF Partnership
Leprosy as a social as well as medical issue

Dr. Shigeki Sakamoto, former Member of the Advisory Committee to the United Nations Human Rights Council (2008–2013)

For five years (1995-1999), The Nippon Foundation (TNF) provided the World Health Organization (WHO) with US$10 million per year so that multidrug therapy (MDT) could be distributed to all leprosy patients worldwide free of charge. Read more 

 

VIEWPOINT
Leprosy as a human rights issue in the 21st century

Dr. Beatriz Miranda Galarza, United Nations Special Rapporteur on the elimination of discrimination against persons affected by leprosy (Hansen's disease) and their family members

In June, I presented my first annual report as the United Nations Special Rapporteur on the elimination of discrimination against persons affected by leprosy (Hansen's disease) and their family members to the United Nations Human Rights Council (HRC) in Geneva, Read more 

 

VIEWPOINT
Despite low numbers, the United States offers unique perspectives in the fight against leprosy

Dr. Jessica K. Fairley, Associate Professor of Medicine, Global Health, and Epidemiology, Emory University

The United States has a long history with leprosy, or Hansen's disease (HD), that continues to the present day. While there is debate about whether the bacillus was first introduced to the Americas along with the arrival of Europeans and enslaved Africans 500 years ago... Read more 

 

REPORT
My observations in Kenya, Nigeria, and Ghana

Tesfaye Tadesse Haile, former Managing Director, Ethiopian National Association of Persons Affected by Leprosy (ENAPAL)

As a research consultant for the Sasakawa Health Foundation, I visited six countries in Africa – Kenya, Nigeria, Ghana, Mozambique, Sierra Leone, and Senegal – between February and May of this year to survey the situation of persons affected by leprosy and people's organizations. Read more 

 

INITIATIVE NEWS
Sasakawa Leprosy Initiative Young Scholar Program launches in Indonesia and Colombia

The Sasakawa Leprosy (Hansen's Disease) Initiative, in cooperation with YDTI/PerMaTa South Sulawesi of Indonesia and Felehansen of Colombia, launched a pilot program called the Sasakawa Leprosy Initiative Young Scholar Program in April 2024. Read more 

 

AMBASSADOR'S JOURNAL
Goodwill Ambassador visits Ethiopia to secure cooperation for the Africa Zero Leprosy Conference

From July 23 to 24, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa visited Addis Ababa, Ethiopia, and met with Dr. Ergogie Tesfaye, Minister of Women and Social Affairs; Dr. Mekdes Daba, Minister of Health; and Dr. Owen Laws Kaluwa, WHO Representative to Ethiopia. Read more 

 

BACK ISSUES 

 

We hope that you would enjoy reading the latest Leprosy Bulletin. 

 

 

Takahiro NANRI, Ph.D.
President, Sasakawa Health Foundation

*********************************************************
Sasakawa Leprosy (Hansen's Disease) Initiative
Sasakawa Health Foundation
Tel：81-3-6229-5377, Fax：81-33-6229-5388
email: hansen@shf.or.jp
*********************************************************

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/497ca611-1f23-4a4a-8483-d098d4091cabn%40googlegroups.com.